Daiichi Sankyo and Kitasato Pharma to terminate sales agreement of Influenza HA vaccine

Daiichi Sankyo Company, Limited and Kitasato Pharmaceutical Industry Co., Ltd. (hereinafter, “ Kitasato Pharmaceutical Industry”) announced the termination of their cooperative sales agreement for Influenza HA Vaccine “Daiichi Sankyo” 1 mL and Influenza HA Vaccine Syringe “Daiichi Sankyo” 0.25 mL and 0.5 mL on March 31, 2020 in Japan.

source https://www.pharmatutor.org/pharma-news/2020/daiichi-sankyo-and-kitasato-pharma-to-terminate-sales-agreement-of-influenza-ha-vaccine